Pharmaceutical Research Overview
COMBIVENT PG Boehringer Ingelheim is a combination pharmaceutical formulation containing ipratropium bromide and albuterol sulfate in a pressurised metered-dose inhaler configuration. This dual-bronchodilator preparation combines an anticholinergic agent with a beta-2 adrenergic agonist, representing an established therapeutic approach in respiratory pharmacology research. The combination mechanism involves complementary pathways: ipratropium bromide blocks muscarinic receptors in bronchial smooth muscle, while albuterol acts as a selective beta-2 receptor agonist. Research scientists investigating bronchodilation mechanisms, inhaled drug delivery systems, and combination therapy approaches often examine this pharmaceutical reference standard. The pressurised delivery system utilises hydrofluoroalkane propellants, making it relevant for inhalation technology studies. Our Stroid UK Shop maintains pharmaceutical-grade standards for laboratory applications.
Laboratory Applications
Researchers utilise COMBIVENT PG preparations in pulmonary function studies, examining bronchodilator synergy between anticholinergic and beta-agonist mechanisms. The combination formulation enables investigation of dual-pathway bronchodilation in respiratory tissue models and inhalation delivery research. Pharmaceutical scientists study the metered-dose inhaler technology for drug delivery optimisation and propellant system analysis. Pharmacokinetic researchers examine the absorption characteristics of combination bronchodilator formulations through respiratory epithelia. The dual-active formulation serves as a reference standard in comparative effectiveness studies within our other drugs research category. Additionally, formulation scientists investigate stability profiles and compatibility studies of combination inhalation products. Quality control laboratories utilise authentic pharmaceutical references for analytical method development and validation protocols. Beyond respiratory applications, researchers exploring SARMs and peptides may require pharmaceutical controls in comparative bioavailability studies.
Technical Specifications
| Parameter | Specification |
|---|---|
| Active Components | Ipratropium bromide + Albuterol sulfate |
| Manufacturer | Boehringer Ingelheim |
| Formulation Type | Pressurised metered-dose inhaler |
| Propellant System | HFA-based formulation |
| Storage Requirements | Room temperature, avoid extreme heat |
| Research Applications | Bronchodilator studies, inhalation delivery |
| Quality Standard | Pharmaceutical reference grade |
Research Compliance
This pharmaceutical preparation is supplied exclusively for legitimate in-vitro laboratory research, analytical method development, and academic investigation into bronchodilator mechanisms and inhalation delivery systems. Not intended for human administration or therapeutic use. Researchers must comply with institutional guidelines and applicable regulations when handling pharmaceutical reference materials. Proper laboratory safety protocols and disposal procedures must be observed during research activities.
